56 related articles for article (PubMed ID: 15745795)
1. Identification of small molecule inhibitors of the hepatitis C virus RNA-dependent RNA polymerase from a pyrrolidine combinatorial mixture.
Burton G; Ku TW; Carr TJ; Kiesow T; Sarisky RT; Lin-Goerke J; Baker A; Earnshaw DL; Hofmann GA; Keenan RM; Dhanak D
Bioorg Med Chem Lett; 2005 Mar; 15(6):1553-6. PubMed ID: 15745795
[TBL] [Abstract][Full Text] [Related]
2. Optimization of novel acyl pyrrolidine inhibitors of hepatitis C virus RNA-dependent RNA polymerase leading to a development candidate.
Slater MJ; Amphlett EM; Andrews DM; Bravi G; Burton G; Cheasty AG; Corfield JA; Ellis MR; Fenwick RH; Fernandes S; Guidetti R; Haigh D; Hartley CD; Howes PD; Jackson DL; Jarvest RL; Lovegrove VL; Medhurst KJ; Parry NR; Price H; Shah P; Singh OM; Stocker R; Thommes P; Wilkinson C; Wonacott A
J Med Chem; 2007 Mar; 50(5):897-900. PubMed ID: 17269759
[TBL] [Abstract][Full Text] [Related]
3. A highly efficient, asymmetric synthesis of benzothiadiazine-substituted tetramic acids: potent inhibitors of hepatitis C virus RNA-dependent RNA polymerase.
Fitch DM; Evans KA; Chai D; Duffy KJ
Org Lett; 2005 Nov; 7(24):5521-4. PubMed ID: 16288546
[TBL] [Abstract][Full Text] [Related]
4. Identification of novel HCV RNA-dependent RNA polymerase inhibitors using pharmacophore-guided virtual screening.
Kim J; Kim KS; Kim DE; Chong Y
Chem Biol Drug Des; 2008 Dec; 72(6):585-91. PubMed ID: 19090925
[TBL] [Abstract][Full Text] [Related]
5. 3-(1,1-dioxo-2H-(1,2,4)-benzothiadiazin-3-yl)-4-hydroxy-2(1H)-quinolinones, potent inhibitors of hepatitis C virus RNA-dependent RNA polymerase.
Tedesco R; Shaw AN; Bambal R; Chai D; Concha NO; Darcy MG; Dhanak D; Fitch DM; Gates A; Gerhardt WG; Halegoua DL; Han C; Hofmann GA; Johnston VK; Kaura AC; Liu N; Keenan RM; Lin-Goerke J; Sarisky RT; Wiggall KJ; Zimmerman MN; Duffy KJ
J Med Chem; 2006 Feb; 49(3):971-83. PubMed ID: 16451063
[TBL] [Abstract][Full Text] [Related]
6. An efficient, asymmetric solid-phase synthesis of benzothiadiazine-substituted tetramic acids: potent inhibitors of the hepatitis C virus RNA-dependent RNA polymerase.
Evans KA; Chai D; Graybill TL; Burton G; Sarisky RT; Lin-Goerke J; Johnston VK; Rivero RA
Bioorg Med Chem Lett; 2006 Apr; 16(8):2205-8. PubMed ID: 16455253
[TBL] [Abstract][Full Text] [Related]
7. A homogeneous, solid-phase assay for hepatitis C virus RNA-dependent RNA polymerase.
Wang YK; Rigat KL; Roberts SB; Gao M
Anal Biochem; 2006 Dec; 359(1):106-11. PubMed ID: 17054898
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological characterization of B-ring amino analogues of potent benzothiadiazine hepatitis C virus polymerase inhibitors.
Randolph JT; Flentge CA; Huang PP; Hutchinson DK; Klein LL; Lim HB; Mondal R; Reisch T; Montgomery DA; Jiang WW; Masse SV; Hernandez LE; Henry RF; Liu Y; Koev G; Kati WM; Stewart KD; Beno DW; Molla A; Kempf DJ
J Med Chem; 2009 May; 52(10):3174-83. PubMed ID: 19402666
[TBL] [Abstract][Full Text] [Related]
9. Human immunodeficiency virus-reverse transcriptase inhibition and hepatitis C virus RNA-dependent RNA polymerase inhibition activities of fullerene derivatives.
Mashino T; Shimotohno K; Ikegami N; Nishikawa D; Okuda K; Takahashi K; Nakamura S; Mochizuki M
Bioorg Med Chem Lett; 2005 Feb; 15(4):1107-9. PubMed ID: 15686922
[TBL] [Abstract][Full Text] [Related]
10. Binding-site identification and genotypic profiling of hepatitis C virus polymerase inhibitors.
Pauwels F; Mostmans W; Quirynen LM; van der Helm L; Boutton CW; Rueff AS; Cleiren E; Raboisson P; Surleraux D; Nyanguile O; Simmen KA
J Virol; 2007 Jul; 81(13):6909-19. PubMed ID: 17459932
[TBL] [Abstract][Full Text] [Related]
11. Simple but highly effective three-dimensional chemical-feature-based pharmacophore model for diketo acid derivatives as hepatitis C virus RNA-dependent RNA polymerase inhibitors.
Di Santo R; Fermeglia M; Ferrone M; Paneni MS; Costi R; Artico M; Roux A; Gabriele M; Tardif KD; Siddiqui A; Pricl S
J Med Chem; 2005 Oct; 48(20):6304-14. PubMed ID: 16190757
[TBL] [Abstract][Full Text] [Related]
12. Identification and characterization of mutations conferring resistance to an HCV RNA-dependent RNA polymerase inhibitor in vitro.
Lu L; Dekhtyar T; Masse S; Pithawalla R; Krishnan P; He W; Ng T; Koev G; Stewart K; Larson D; Bosse T; Wagner R; Pilot-Matias T; Mo H; Molla A
Antiviral Res; 2007 Oct; 76(1):93-7. PubMed ID: 17561278
[TBL] [Abstract][Full Text] [Related]
13. Docking ligands into flexible and solvated macromolecules. 2. Development and application of fitted 1.5 to the virtual screening of potential HCV polymerase inhibitors.
Corbeil CR; Englebienne P; Yannopoulos CG; Chan L; Das SK; Bilimoria D; L'heureux L; Moitessier N
J Chem Inf Model; 2008 Apr; 48(4):902-9. PubMed ID: 18341269
[TBL] [Abstract][Full Text] [Related]
14. Antiviral interactions of an HCV polymerase inhibitor with an HCV protease inhibitor or interferon in vitro.
Koev G; Dekhtyar T; Han L; Yan P; Ng TI; Lin CT; Mo H; Molla A
Antiviral Res; 2007 Jan; 73(1):78-83. PubMed ID: 16945431
[TBL] [Abstract][Full Text] [Related]
15. Selective inhibitors of hepatitis C virus replication.
Neyts J
Antiviral Res; 2006 Sep; 71(2-3):363-71. PubMed ID: 16843538
[TBL] [Abstract][Full Text] [Related]
16. Discovery and optimization of (R)-prolinol-derived agonists of the Growth Hormone Secretagogue receptor (GHSR).
Zhai W; Flynn N; Longhi DA; Tino JA; Murphy BJ; Slusarchyk D; Gordon DA; Pendri A; Shi S; Stoffel R; Ma B; Sofia MJ; Gerritz SW
Bioorg Med Chem Lett; 2008 Sep; 18(18):5083-6. PubMed ID: 18722770
[TBL] [Abstract][Full Text] [Related]
17. Parallel synthesis of chiral pentaamines and pyrrolidine containing bis-heterocyclic libraries. Multiple scaffolds with multiple building blocks: a double diversity for the identification of new antitubercular compounds.
Nefzi A; Appel J; Arutyunyan S; Houghten RA
Bioorg Med Chem Lett; 2009 Sep; 19(17):5169-75. PubMed ID: 19632841
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of potent pyrrolidine influenza neuraminidase inhibitors.
Krueger AC; Xu Y; Kati WM; Kempf DJ; Maring CJ; McDaniel KF; Molla A; Montgomery D; Kohlbrenner WE
Bioorg Med Chem Lett; 2008 Mar; 18(5):1692-5. PubMed ID: 18242993
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and SAR of novel 1,1-dialkyl-2(1H)-naphthalenones as potent HCV polymerase inhibitors.
Bosse TD; Larson DP; Wagner R; Hutchinson DK; Rockway TW; Kati WM; Liu Y; Masse S; Middleton T; Mo H; Montgomery D; Jiang W; Koev G; Kempf DJ; Molla A
Bioorg Med Chem Lett; 2008 Jan; 18(2):568-70. PubMed ID: 18068361
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, and antiviral activity of 2'-deoxy-2'-fluoro-2'-C-methylcytidine, a potent inhibitor of hepatitis C virus replication.
Clark JL; Hollecker L; Mason JC; Stuyver LJ; Tharnish PM; Lostia S; McBrayer TR; Schinazi RF; Watanabe KA; Otto MJ; Furman PA; Stec WJ; Patterson SE; Pankiewicz KW
J Med Chem; 2005 Aug; 48(17):5504-8. PubMed ID: 16107149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
